AstraZeneca
AZN
#42
Rank
NZ$534.26 B
Marketcap
NZ$344.63
Share price
1.49%
Change (1 day)
33.54%
Change (1 year)

AstraZeneca (AZN) - Cash on Hand

Cash on Hand as of December 2025 : NZ$10.01 Billion

According to AstraZeneca's latest financial reports the company has NZ$10.01 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

AstraZeneca - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31NZ$9.87 B0.8%
2024-12-31NZ$9.79 B5.72%
2023-12-31NZ$9.26 B-5.76%
2022-12-31NZ$9.83 B4.98%
2021-12-31NZ$9.36 B-15.43%
2020-12-31NZ$11.07 B19.99%
2019-12-31NZ$9.23 B10.69%
2018-12-31NZ$8.33 B30.06%
2017-12-31NZ$6.41 B-23.56%
2016-12-31NZ$8.38 B-14.85%
2015-12-31NZ$9.85 B9.63%
2014-12-31NZ$8.98 B-25.36%
2013-12-31NZ$12.04 B20.45%
2012-12-31NZ$9.99 B-30.81%
2011-12-31NZ$14.44 B-5.74%
2010-12-31NZ$15.32 B-2.36%
2009-12-31NZ$15.69 B107.47%
2008-12-31NZ$7.56 B-2.72%
2007-12-31NZ$7.77 B-28.69%
2006-12-31NZ$10.90 B49.73%
2005-12-31NZ$7.28 B-1.27%
2004-12-31NZ$7.37 B21.4%
2003-12-31NZ$6.07 B-32.15%
2002-12-31NZ$8.95 B-2.7%
2001-12-31NZ$9.20 B-8.37%
2000-12-31NZ$10.04 B59.69%
1999-12-31NZ$6.29 B-2.82%
1998-12-31NZ$6.47 B211.76%
1997-12-31NZ$2.07 B-12.13%
1996-12-31NZ$2.36 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
NZ$35.20 B 251.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$20.20 B 101.66%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$23.81 B 137.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$15.65 B 56.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$12.72 B 27.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$17.42 B 73.92%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
NZ$6.68 B-33.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$25.51 B 154.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$18.69 B 86.62%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$7.45 B-25.61%๐Ÿ‡ฌ๐Ÿ‡ง UK